Title of article
The Association between Acute Cardiac Injury and Outcomes of Hospitalized Patients with COVID-19: Long-term Follow-up Results from the Sina Hospital COVID-19 Registry, Iran
Author/Authors
Soltani ، Danesh Cardiac Primary Prevention Research Center (CPPRC), Cardiovascular Diseases Research Institute - Tehran University of Medical Sciences , Hadadi ، Azar Department of Infectious Diseases - Sina Hospital - Tehran University of Medical Sciences , Karbalai Saleh ، Shahrokh Department of Cardiology - Sina Hospital - Tehran University of Medical Sciences , Oraii ، Alireza Department of Cardiology - Sina Hospital - Tehran University of Medical Sciences , Sadatnaseri ، Azadeh Department of Cardiology - Sina Hospital - Tehran University of Medical Sciences , Roozitalab ، Mostafa Department of Cardiology - Sina Hospital - Tehran University of Medical Sciences , Shajari ، Zahra Department of Cardiology - Sina Hospital - Tehran University of Medical Sciences , Ghaemmaghami ، Shima sadat Research Development Center, Sina Hospital - Tehran University of Medical Sciences , Ashraf ، Haleh Cardiac Primary Prevention Research Center (CPPRC), Cardiovascular Diseases Research Institute, Research Development Center, Sina Hospital - Tehran University of Medical Sciences
From page
196
To page
206
Abstract
Background: The present study aimed to investigate the association between acute cardiac injury (ACI) and outcomes in hospitalized patients with coronavirus disease 2019 (COVID-19) in Iran. Methods: The current cohort study enrolled all consecutive hospitalized patients with COVID-19 (≥ 18 y) who had serum high-sensitivity cardiac troponin-I (hs-cTnT) measurements on admission between March 2020 and March 2021. ACI was determined as hs-cTnT levels exceeding the 99th percentile of normal values. Data on demographics, comorbidities, clinical and laboratory characteristics, and outcomes were collected from Web-based electronic health records. Results: The study population consisted of 1413 hospitalized patients with COVID-19, of whom 319 patients (22.58%) presented with ACI. The patients with ACI had a significantly higher mortality rate than those without ACI (48.28% vs 15.63%; P 0.001) within a mean follow-up of 218.86 days from symptom onset. ACI on admission was independently associated with mortality (HR, 1.44; P=0.018). In multivariable logistic regression, age (OR, 1.034; P 0.001), preexisting cardiac disease (OR, 1.49; P=0.035), preexisting malignancy (OR, 2.01; P=0.030), oxygen saturation reduced to less than 90% (OR, 2.15; P 0.001), leukocytosis (OR, 1.45; P=0.043), lymphopenia (OR, 1.49; P=0.020), reduced estimated glomerular filtration rates (eGFRs) (OR, 0.99; P=0.008), and treatment with intravenous immunoglobulin during hospitalization (OR, 4.03; P=0.006) were independently associated with ACI development. Conclusion: ACI occurrence on admission was associated with long-term mortality in our hospitalized patients with COVID-19. The finding further underscores the significance of evaluating ACI occurrence on admission, particularly in individuals more prone to ACI, including older individuals and those with preexisting comorbidities, reduced oxygen saturation, and increased inflammatory responses.
Keywords
COVID , 19 , SARS , CoV , 2 , Troponin , Mortality
Journal title
The Journal of Tehran University Heart Center (JTHC)
Journal title
The Journal of Tehran University Heart Center (JTHC)
Record number
2762982
Link To Document